The following research study is enrolling. For information about the drug, see Spotlight on Teriflunomide (pdf) in The International MS Journal 2008; 15:62-68. And...here is information found on ClinicalTrials.gov regarding Teriflunomide.
A Clinical Research Study Evaluating An Investigational Medication for Relapsing Forms of Multiple Sclerosis
Medical researchers are enrolling people in a worldwide clinical research study for people with relapsing forms of multiple sclerosis (RMS). This study will assess the safety and effectiveness of an investigational study medication versus placebo (an inactive substance which contains no active medication) in people ages 18-55 years old with RMS.
The investigational medication used in this study is called teriflunomide (ter-i-flün-ō-mïde). It is derived from leflunomide (le-flü-nō-mïde), also known as Arava®. Arava® is already approved in many countries for the treatment of rheumatoid arthritis, another autoimmune disease.
The first step in determining eligibility for this study is to take the pre-screening questionnaire either online or on the phone. You will be asked a series of questions related to your health and be given additional information about study site locations. Visit www.tower3.msstudies.com or call 1-866-565-0246 today to learn more about the study and see if you may qualify.
I posted this same thing this afternoon. We must have gotten similar emails. :)
ReplyDeleteA commercial for this study is running on TV in my state. My husband asked if I was going to look into it. My answer was no. I have been turned down for three studies in the past, when I was first diagnosis; therefore, I no longer bother to go through the process.
ReplyDeleteI just posted this too. I'll be curious to hear the results although I myself won't be enrolling in the trial.
ReplyDelete